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Abstract
Background—Medication discrepancies are unintended differences between medication
regimens (ie, between a patient’s home regimen and medications prescribed on admission to the
hospital).
Objective—The goal of this study was to describe the incidence, drug classes, and probable
importance of hospital admission medication discrepancies and discharge regimen differences, and
to determine whether factors such as age and specific hospital services were associated with
greater frequency of medication discrepancies and differences.
Methods—This was a retrospective cohort study of a random sample of adult patients admitted
to the general medicine, cardiology, or general surgery services of a tertiary care academic
teaching hospital between July 1, 2006, and August 31, 2006. A chart review was performed to
collect the following information: patient demographic characteristics, comorbid conditions,
number of preadmission medications, discrepant medications identified by the hospital’s
reconciliation process, reasons for the discrepancies, and discharge medications that differed from
the home regimen. Potentially high-risk discrepancies and differences were identified by
determining if the medications were included on either the Institute for Safe Medication Practices
high-alert list or the North Carolina Narrow Therapeutic Index list. Univariate and multivariate
logistic regression analyses were used to identify factors associated with medication discrepancies
and differences.
Results—Of the 205 patients (mean age, 59.9 years; 116 men, 89 women; 60% white) included
in the study, 27 did not have any medications recorded on admission. Of the 178 patients who did
have medications listed, 41 had ≥1 discrepancy identified by the reconciliation process on
admission (23%; 95% CI, 17–29); 19% (95% CI, 11–31) of these medications were considered to
be potentially high risk. In the multivariate logistic regression model, age (odds ratio [OR] per 5-
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year increase = 1.16; 95% CI, 1.01–1.33; P = 0.035), presence of high-risk medications on
admission (OR = 76.68; 95% CI, 9.13–643.76; P < 0.001), and general surgery service (OR =
3.31; 95% CI, 1.40–7.87; P < 0.007) were associated with a higher proportion of patients with
discrepancies on admission. At discharge, 196 patients (96% [95% CI, 93–98]) had ≥1 medication
change from their home regimen, with 1102 total differences for 205 patients. Less than half (44%
[95% CI, 37–51]) of these patients were explicitly alerted at discharge to new medications or dose
changes; 12% (95% CI, 7–18) were given written instructions to stop taking discontinued home
medications. Cardiovascular drugs were the most frequent class involved at both admission (31%)
and discharge (27%) in medication discrepancies or differences.
Conclusions—Medication discrepancies on admission and medication differences at discharge
were prevalent for adult patients admitted to the general medicine, cardiology, and general surgery
services in this academic teaching hospital. Medication reconciliation processes have a high
potential to identify clinically important discrepancies for all patients.
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INTRODUCTION
Medications are a critical tool in the practice of modern medicine; one third of Americans
take ≥5 medications.1 When patients enter the hospital setting, medications may be
temporarily withheld, new medications may be added to treat acute processes, and chronic
medications may be changed. Hospitalized patients are thus at high risk for experiencing
abrupt medication changes and errors that may result in adverse drug events (ADEs).
Medication discrepancies are unintended differences between medication regimens (ie,
between a patient’s home regimen and medications prescribed on admission to the hospital).
These discrepancies range in severity and may include omission of medications, wrong
medication name, and incorrect dosing. Older patients who are more likely to have chronic
conditions, visit more providers, and take a greater number of medications may be at
particularly high risk for ADEs related to medication discrepancies.
ADEs are unfortunately both common and costly in the hospital setting.1,2 Using previous
research, the Institute of Medicine reported that a conservative annual estimate of 400,000
in-hospital preventable ADEs would cost $3.5 billion in 2006 dollars.1 Increased costs can
be due to increases in length of stay or pharmacy and laboratory costs.3,4 Reducing
preventable ADEs is therefore an important goal for both providers and health care system
administrators.
A particularly high-risk time for preventable ADEs is when patients transition from one
health care setting to another. Prior studies have found that more than half of general
internal medicine patients and patients admitted to acute care services have ≥1 unintended
medication discrepancy on admission.5,6 Other studies have reported that medication
discrepancies, including those more likely to cause potential ADEs, were more common at
discharge than on admission.7,8 One prospective study of 180 general medicine patients
found that 75% of preventable ADEs occurred at discharge.7 A study testing the
effectiveness of a multidisciplinary medication reconciliation process found that, before the
intervention, there was a mean of 0.5 admission medication discrepancy and 3.3 discharge
medication discrepancies per patient.8
In addition to the unintended discrepancies between a patient’s prior home regimen and
hospital discharge orders, failure to adequately communicate the planned medication
regimen to patients and other care providers at transition points may lead to ADEs or
Unroe et al. Page 2













therapeutic failure.5,9–11 In a study of patients aged ≥65 years who were recently discharged
from the hospital, 14% had discrepancies between what they were actually taking and what
was prescribed at discharge.11
Detection and management of medication discrepancies to reduce ADEs are a major focus
of patient safety efforts. As part of the National Patient Safety Goals program, the Joint
Commission on Accreditation of Healthcare Organizations (JCAHO) issued a mandate in
2005 requiring hospitals to perform medication reconciliation at each transition of care.12
According to the JCAHO, a process should be in place for comparing the patient’s present
medications with those ordered, and a complete list of the patient’s medications must be
communicated to the next provider of care. Furthermore, a complete list of medications
should be provided to the patient at discharge. However, in recognition of the difficulties
that many organizations are having in meeting these requirements, the JCAHO decided in
February 2009 not to consider medication reconciliation in accreditation decisions until the
policy was reviewed further, although it continues to monitor progress in this area.13
Health care organizations have responded to the JCAHO mandate with various approaches
to medication reconciliation, including development of forms completed by nurses and
confirmed by physicians, the use of case managers to perform reconciliation, and tools
developed using information technology.8,14–21 Although data on the effectiveness of these
various options are limited, some of the programs have successfully reduced the number and
severity of discrepancies using an interdisciplinary process.8,18 Some have even found
reductions in rehospitalization rates when using medication reconciliation in addition to
other tools.22–24 Dedhia et al22 tested a geriatric-specific discharge planning tool that
included medication reconciliation and found that fewer intervention patients required a
return emergency department visit or hospital readmission compared with a preintervention
group (3% vs 10%; odds ratio [OR] = 0.25; 95% CI, 0.10–0.62). Another study also
assessed elderly inpatients assigned to a discharge planning and education intervention
program that included medication reconciliation and counseling, in addition to a follow-up
phone call after discharge. They reported fewer emergency department visits and
readmissions at 30 days versus a control group (10.0% vs 38.1%; P = 0.04).24
To contribute to the growing literature on medication discrepancies and the reconciliation
process, the present study was designed to describe the frequency of discrepancies in
admission medications, the medication classes involved, and the factors associated with
these discrepancies. All differences between admission and discharge medication lists were
recorded, and the manner in which these were communicated to patients was examined. The
goal was to determine whether age and specific hospital services were associated with a
higher risk of medication discrepancies or differences. We identified which of these might
be considered “higher risk” based on the medication class involved. In addition, the
discharge list of medications given to patients and the dictated discharge summaries for the
next provider of care were compared, with the aim of identifying unmet communication and
education needs.
PATIENTS AND METHODS
Medication Reconciliation Process Admission
For the purposes of this study, medication discrepancies were defined as any changes in a
patient’s previous medications that were identified by an inpatient pharmacist as unintended
and potentially clinically relevant at the time of the patient’s admission. For example, the
omission of furosemide in a patient admitted for dehydration would be considered an
intended medication change and would not be considered a discrepancy for this analysis.
Pharmacists recorded if the medication had been omitted or was the wrong dose or
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frequency in many cases, but if the medication was simply listed as discrepant without
further description, it was categorized as not specified.
This study was conducted at Duke University Medical Center (Durham, North Carolina). At
this academic teaching hospital, pharmacist medication reconciliation on admission had
been initiated in January 2006, which was before the start of our study. The policy was that,
within 48 hours of admission, a clinical pharmacist reviewed the patient medication his-
tories obtained by the provider and the nurse, and compared them with medications
prescribed on admission for the patient. Approximately 25 clinical pharmacists performed
medication reconciliation throughout the hospital. Front-line managers of clinical
pharmacist staff provided education and training regarding the medication reconciliation
process as established in-hospital policy. Each pharmacist was provided with a hard copy of
the manual, which included relevant algorithms and documents describing the medication
reconciliation procedure. In addition to medication reconciliation, these pharmacists
assessed and recommended appropriate, evidence-based medication therapies for patients,
evaluated and reported ADEs, and provided pharmacokinetic and/or drug-specific
monitoring.
When discrepancies were found, the pharmacist investigated further by talking with the
patient, the patient’s caregiver, the admitting physician, or the referring physician, or by
calling the patient’s pharmacy. The pharmacist reviewed the physician-completed history
and physical for documentation of intentional differences between preadmission medications
and those started on admission (ie, medications held in antici- pation of surgery), and these
were not counted as discrepancies. Discrepancies that were judged by the pharmacist to be
clinically relevant were noted in the patient’s chart. The pharmacist developed a reconciled
preadmission medication list and resolved any discrepancies with admission orders with the
prescribing physician. Through this process, all discrepancies were brought to the attention
of the inpatient provider and resolved after discussion with the pharmacist. Thus, for
admission, the medication reconciliation performed by the inpatient pharmacists was used as
part of the hospital’s standard process.
Discharge
The hospital had not yet instituted a discharge medication reconciliation process at the time
of this study. For discharge, the investigators performed the reconciliation by comparing
admission and discharge medication lists. Because this was done retrospectively, it was not
possible to determine how many changes were unintended versus intended, and they were
noted as differences. Any inconsistencies in medication lists between the discharge papers
given to patients and the dictated discharge summaries for providers were considered
unintended and recorded as discrepancies because these 2 lists should have been identical.
Patient Selection
A retrospective chart review was conducted for a random sample of adult patients admitted
to the general medicine, cardiology, or general surgery services of a 954-bed tertiary care
academic teaching hospital between July 1, 2006, and August 31, 2006. These 3 ser- vices
were chosen because of their high volume and broad patient population. The charts were
randomly selected, using a computer-generated random number list, from a record of all
patients admitted during the study period. Patients initially admitted to an intensive care unit
or transferred from an outside hospital were excluded because admission medication
reconciliation should already have occurred.
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Medical records were abstracted into a Microsoft Access database (Microsoft Corporation,
Redmond, Washington) by 2 of the investigators, a physician (K.T.U.) and a pharmacy
student (S.R.). Both paper records (admission history from the medical team, preadmission
medication list from the nursing team, pharmacist medication reconciliation note, and
patient discharge instruction sheet) and electronic records (discharge summary) were used.
Reliability was ensured by having both investigators independently review a random 10%
sample of patient charts and demonstrate that simple agreement exceeded 90%. All
questions that arose in interpreting data were resolved by consensus during study team
meetings.
Variables
Information including patient demographic characteristics, comorbid conditions, and
number of medications was abstracted from the admission records. Discrepancies on
admission and differences at discharge were recorded as described earlier.
Written discharge instructions were also examined for instructions regarding the medication
differences (eg, whether the patient was explicitly instructed to stop or change the dose of a
previous home medication that had been discontinued or dose adjusted). Patient discharge
instructions were also compared with dictated discharge summaries, which are routinely sent
to follow-up care providers, and any inconsistencies between these 2 lists of medications
were recorded as discrepancies.
Potentially high-risk admission discrepancies and discharge differences were identified by
determining if the medications were included on the Institute for Safe Medication Practices
(ISMP) high-alert list or the North Carolina Narrow Therapeutic Index (NTI) list (Table
I).25,26 The medications on these lists have a higher risk of patient harm, a higher risk of
subtherapeu-tic and supratherapeutic drug concentrations, or both.
Statistical Analysis
Baseline characteristics were compared among services using the Wilcoxon signed rank test
for continuous variables, and the Pearson χ2 test or the Fisher exact test (when expected cell
count was <5) for categorical variables. The data were analyzed using descriptive statistics
to determine, overall and by admitting service, the proportion of patients with ≥1 admission
discrepancy identified, the proportion of medications by classes that were discrepant, and
the types of discrepancies. The proportion of potentially high-risk discrepant medications,
overall and by admitting service, was estimated using logistic regression, accounting for
within-patient correlation between medications. Similar analyses were performed to assess
discharge medication differences. Univariate and multivariate logistic regression analyses
were conducted where the response variable was presence or absence of any medication
discrepancies for admission and differences for discharge. The variables considered for
inclusion in both admission and discharge models were age, sex, race, number of co- morbid
conditions, admitting service, number of pre-admission medications, and presence of
preadmission high-risk medications; length of hospital stay was additionally considered for
the discharge model.
This study was approved by the institutional review board of Duke University Medical
Center.
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A total of 205 patients (mean age, 59.9 years; 116 men, 89 women; 60% white) were
included in the study. Age, sex, and race distribution did not differ statistically among the 3
services (Table II). Cardiology patients had a higher mean number of comorbid conditions
(5.2), followed by general medicine patients (4.0) (P < 0.001). General surgery patients had
the longest mean length of stay (5.4 days) (P = 0.002).
Admission
Of the 205 patients in the study, 27 did not have any medications recorded on admission. Of
the 178 patients who did have medications listed, 41 had ≥1 discrepancy noted (23%; 95%
CI, 17–29). On the cardiology service, 9 patients (15%; 95% CI, 6–24) had discrepant
medications; 14 general medicine patients (22%; 95% CI, 11–32) and 18 general surgery
patients (35%; 95% CI, 22–49) also had ≥1 medication discrepancy. The proportion of
patients with discrepancies on admission differed significantly among the 3 services (P =
0.03).
Of the admission medications that were found to be discrepant, 19% (95% CI, 11–31) were
considered potentially high risk based on ISMP and NTI classifications. The proportion of
high-risk discrepancies was not significantly different among the 3 services.
Cardiovascular medications represented 31% (n = 25) of all discrepancies on admission,
followed by hormone-modifying agents, hematologic/oncologic medications (including
chemotherapeutic agents or adjuvant therapies), and central nervous system agents (all, 12%
[n = 10]) (Table III). Medication omissions accounted for 37% (n = 30) of admission
discrepancies, and 4% (n = 3) were wrong dose or frequency. The type of discrepancy was
not specified by the pharmacist in 59% of cases (n = 48).
In the univariate logistic regression analysis of medication discrepancies on admission,
presence of high-risk medications (OR = 63.14; 95% CI, 7.93–502.45) and admitting service
(OR = 3.21; 95% CI, 1.29–7.98 for general surgery vs cardiology) were significantly
associated with a higher proportion of patients with discrep- ancies (P < 0.001 and 2 df, P =
0.036, respectively) (Table IV). In the multivariate logistic regression model, age (OR per 5-
year increase = 1.16; 95% CI, 1.01–1.33; P = 0.035), presence of high-risk medications (OR
= 76.68; 95% CI, 9.13–643.76; P < 0.001), and general surgery service (OR = 3.31; 95% CI,
1.40–7.87; P < 0.007) were associated with a higher proportion of patients with
discrepancies on admission.
Discharge
For the 205 patients in this study, 196 (96%; 95% CI, 93–98) had ≥1 medication difference
(mean, 5.4; range, 0–18) at discharge compared with their admission medications listing.
Patients discharged from the cardiology service had 50% (95% CI, 43–57) of their
medications changed at discharge; general medicine patients had 58% changed (95% CI,
51–65) and general surgery patients had 66% changed (95% CI, 58–73). There were 1102
total differences at discharge noted for these 205 patients. Cardiovascular medications were
the most frequent class involved (27% [n = 298]) (Table V). Central nervous system,
gastrointestinal, antimicrobial, and hematologic/oncologic medications represented 14% (n
= 149), 11% (n = 126), 11% (n = 121), and 9% (n = 99) of differences, respectively. A total
of 560 agents (51%) were newly added medications, 304 (28%) were discontinued
medications, and 118 (11%) were dose changes of previous medications; 120 (11%) were
classified as other medication activity.
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Potentially high-risk medications represented 18% of the discharge differences (95% CI,
15–20). Per hospital service, this ranged from 13% (95% CI, 10–18) for cardiology, 18%
(95% CI, 13–23) for general medicine, and 21% (95% CI, 17–25) for general surgery. The
proportion of high-risk medications was significantly different between admitting services
(2 df, P = 0.028). The proportion of high-risk medications for cardiology patients was
significantly different from that for general surgery patients (P = 0.008).
Less than half of the study patients (44% [95% CI, 37–51]) were explicitly alerted to new
medications or dose changes on their discharge paperwork. Of those patients who had home
medications that were discontinued at discharge, 12% (95% CI, 7–18) were given written
instructions to stop taking them. Such instructions had to be written out in free text on the
discharge paperwork by the discharging provider.
Overall, 35% (95% CI, 28–41) of patients had discrepancies between the patient discharge
paperwork and the dictated discharge summary. By service, 29% (95% CI, 18–40) of
cardiology patients, 38% (95% CI, 27–50) of general medicine patients, and 38% (95% CI,
25–50) of general surgery patients had discrepancies between the discharge medication lists
(Table VI).
Only the presence of high-risk medication was significantly associated with a higher
likelihood of medication differences at discharge (OR = 9.47; 95% CI, 1.12–80.22; P =
0.039), although CIs were wide due to the low prevalence of high-risk medications at
admission and the large proportion of patients with ≥1 discharge difference (Table VII).
DISCUSSION
Hospitals across the country are at various stages of implementation of the JCAHO-
mandated medication reconciliation at admission and discharge.13 This is a resource-
intensive process, and it is important to target efforts in ways that maximize the impact on
patient safety. In the present study, pharmacists recorded unintended discrepancies between
home medication lists and admission medications for 23% of patients. Many of these
discrepancies were in classes of medications that have been previously documented to pose
a high risk for ADEs.25,26 Our findings are similar to other research on general medicine
services,7 and we extended them to include cardiology and general surgery services.
We found that nearly all patients (196 of 205) left the hospital with changes in their
medication regimens and many did not receive written instructions highlighting these
changes (only 12% of those who had preadmission medications discontinued were explicitly
told to stop taking them at discharge). Discrepancies between dictated discharge summaries
and written patient instructions are a potential source of confusion for patients and their next
provider of care, and there is an urgent need for the development of effective systems to
ensure adequate patient education and communication between providers. This will almost
certainly require health care systems to allocate additional funds to accomplish this mandate.
Present reimbursement systems are not constructed to cover or encourage discharge patient
education and communication activities.
There are several important conclusions from this study. First, the process of medication
reconciliation has a high potential to identify and correct medication discrepancies in
hospitalized patients. Second, while increasing age was associated with discrepancies on
admission to the hospital, discrepancies were found across all services and patient groups
studied, suggesting that reconciliation efforts cannot be narrowed to high-risk populations
based on comorbidities or type of inpatient service. It was surprising that the total number of
pre-admission medications was not associated with admission discrepancies. This may be
because the pharmacists did not routinely report substances such as vitamins as discrepant
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and also because medications discontinued for a clinical indication were not reported as
discrepancies. Our results suggest that preadmission medication class, rather than absolute
number of medications, may be the most important predictor of clinically significant
medication discrepancies. The association between high- risk medications and discrepancies
or differences at both admission and discharge suggests that more intensive reconciliation
and education efforts could be targeted toward patients taking these medications. Finally,
although efforts in many health care systems have focused on admission medication
reconciliation, discharge inconsistencies are particularly prevalent, suggesting that
reconciliation, communication, and education efforts at this transition point are urgently
needed.27
In addition to processes implemented by providers and health care system administrators,
some have advocated for the involvement and empowerment of patients and caregivers to
reduce ADEs that occur at transitions of care. Coleman et al28 studied a comprehensive
approach to helping community-dwelling patients aged >65 years through a hospitalization
and discharge to home. Interventions for their care transitions included medication
reconciliation but also development of a personal health record for the patient and
assignment of a transition coach who could both call and visit the patient after discharge.
Testing this intervention in a randomized controlled trial of 750 older adults, the researchers
found statistically significant reductions in rehospitalization rates at 30 days (8.3% vs
11.9%; P = 0.048) and at 90 days (16.7% vs 22.5%; P = 0.04). A recent study in a teaching
hospital in the Netherlands found that medication reconciliation, when coupled with more
intensive patient participation and counseling, re- sulted in a more robust process, with a
greater number of discrepancies identified and corrected.29 In this study, 262 patients (mean
[SD] age, 65 [17.3] years) discharged from an inpatient pulmonary ward received
medication reconciliation with or without counseling by pharmaceutical consultants.
Medication reconciliation was done primarily using electronic medical records of the
hospital and pharmacy. Nearly all patients (97%) who received counseling had ≥1 additional
medication change afterward, either due to another discrepancy that was identified or due to
identified therapeutic needs. In addition, patients received personalized counseling and
education regarding their medications.
The present study helps illustrate why programs that focus on discharge medication
reconciliation can identify and correct these discrepancies. Further studies are needed to
determine whether interventions in younger patients, or less resource-intensive
interventions, might reduce ADEs and rehospitalization rates. Such interventions could
include a follow-up call or single home visit to identify potentially dangerous medication
discrepancies. It is possible that proposals30 to reimburse hospitals less for readmissions will
increase the incentive for the hospital to provide more robust discharge planning,
counseling, and follow-up.
The results of the present study may be generalizable to similar academic medical centers
with a variety of medical and surgical clinical services that serve a demographically similar
population. The primary limitation of this study, however, is that we could not determine
what proportion of the corrected medication discrepancies would have resulted in a
clinically significant ADE. We infer, based on results of previous research,1 that the high
number of discrepant and different medications identified creates a significant potential for
problems. Although a recent retrospective study of nursing home patients reported that only
a small proportion of medication discrepancies resulted in an ADE (65 of 1350),31 this study
relied on chart review that likely underestimated ADE incidence and severity. Our use of the
ISMP and NTI lists alone to identify potentially high-risk discrepancies likely
underestimated the clinical significance of many other discrepancies.
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Another limitation of our retrospective study—and medication reconciliation processes in
general—is that there is no gold standard for obtaining consistent medication histories from
patients. Without an accurate preadmission medication list that reflects what the patient has
been taking at home, the entire process is flawed. Our study, however, was intended to
examine the real-world implementation of medication reconciliation in our hospital and
reflects a standard process for eliciting medication histories by providers. In addition,
providers often give oral instructions to patients regarding discharge medications; however,
because this is not consistently recorded in the chart, this type of counseling could not be
tracked in the present study.
Pharmacist medication reconciliation is an important tool to reduce the risk of medication
discrepancies. However, other models of medication reconciliation, such as use of electronic
personal health records, should be developed and tested. Patient education about medication
regimens and clear communication to the next provider of care are essential for both
regulatory compliance and patient safety.
CONCLUSIONS
Medication discrepancies on admission and medication differences at discharge were
prevalent for adult patients admitted to the general medicine, cardiology, and general
surgery services in this academic medical center. Medication reconciliation processes have a
high potential to identify clinically important discrepancies for all patients.
Acknowledgments
This work was supported with internal funds from Duke University Medical Center. Dr. Colón-Emeric is supported
by Paul A. Beeson Award K23 AG024787.
References
1. Aspden, P.; Wolcott, JA.; Bootman, JL.; Cronenwett, LR., editors. Committee on Identifying and
Preventing Medication Errors. Preventing Medication Errors: Quality Chasm Series. Washington,
DC: The National Academies Press; 2007.
2. Bates DW, Cullen DJ, Laird N, et al. for the ADE Prevention Study Group. Incidence of adverse
drug events and potential adverse drug events. Implications for prevention. JAMA. 1995; 274:29–
34. [PubMed: 7791255]
3. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and
medication errors in United States hospitals. Pharmacotherapy. 2002; 22:134–147. [PubMed:
11837551]
4. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess
length of stay, extra costs, and attributable mortality. JAMA. 1997; 277:301–306. [PubMed:
9002492]
5. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of
hospital admission. Arch Intern Med. 2005; 165:424–429. [PubMed: 15738372]
6. Vira T, Colquhoun M, Etchells E. Reconcilable differences: Correcting medication errors at hospital
admission and discharge. Qual Saf Health Care. 2006; 15:122– 126. [PubMed: 16585113]
7. Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication
reconciliation. J Gen Intern Med. 2008; 23:1414–1422. [PubMed: 18563493]
8. Varkey P, Cunningham J, O’Meara J, et al. Multidisciplinary approach to inpatient medication
reconciliation in an academic setting. Am J Health Syst Pharm. 2007; 64:850–854. [PubMed:
17420202]
9. Lessard S, DeYoung J, Vazzana N. Medication discrepancies affecting senior patients at hospital
admission. Am J Health Syst Pharm. 2006; 63:740–743. [PubMed: 16595814]
Unroe et al. Page 9













10. Forster AJ, Murff HJ, Peterson JF, et al. Adverse drug events occurring following hospital
discharge. J Gen Intern Med. 2005; 20:317–323. [PubMed: 15857487]
11. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: Prevalence and
contributing factors. Arch Intern Med. 2005; 165:1842–1847. [PubMed: 16157827]
12. The Joint Commission. [Accessed January 30, 2009] Sentinel Event Alert: Using medication
reconciliation to prevent errors. http://www.jointcommission.org/SentinelEvents/
SentinelEventAlert/sea_35.htm
13. Approved: Will not score medication reconciliation in 2009. The Joint Commission plans to
review, refine NPSG 8 for 2010. Joint Commission Perspectives. 2009; 29:1–3.
14. Schnipper JL, Hamann C, Ndumele CD, et al. Effect of an electronic medication reconciliation
application and process redesign on potential adverse drug events: A cluster-randomized trial.
Arch Intern Med. 2009; 169:771–780. [PubMed: 19398689]
15. Clay BJ, Halasyamani L, Stucky ER, et al. Results of a medication reconciliation survey from the
2006 Society of Hospital Medicine national meeting. J Hosp Med. 2008; 3:465–472. [PubMed:
19084896]
16. Stover PA, Somers P. An approach to medication reconciliation. Am J Med Qual. 2006; 21:307–
309. [PubMed: 16973946]
17. Levanda M. Implementing a medication reconciliation process in a community hospital. Am J
Health Syst Pharm. 2007; 64:1372–1378. [PubMed: 17592001]
18. Hayes BD, Donovan JL, Smith BS, Hartman CA. Pharmacist-conducted medication reconciliation
in an emergency department. Am J Health Syst Pharm. 2007; 64:1720–1723. [PubMed: 17687061]
19. Poole DL, Chainakul JN, Pearson M, Graham L. Medication reconciliation: A necessity in
promoting a safe hospital discharge. J Healthc Qual. 2006; 28:12–19. [PubMed: 17518010]
20. Kramer JS, Hopkins PJ, Rosendale JC, et al. Implementation of an electronic system for
medication reconciliation [published correction appears in Am J Health Syst Pharm. 2007;64:684].
Am J Health Syst Pharm. 2007; 64:404–422. [PubMed: 17299180]
21. Wortman SB. Medication reconciliation in a community, nonteaching hospital. Am J Health Syst
Pharm. 2008; 65:2047–2054. [PubMed: 18945865]
22. Dedhia P, Kravet S, Bulger J, et al. A quality improvement intervention to facilitate the transition
of older adults from three hospitals back to their homes. J Am Geriatr Soc. 2009; 57:1540–1546.
[PubMed: 19694865]
23. Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease
rehospitalization: A randomized trial. Ann Intern Med. 2009; 150:178– 187. [PubMed: 19189907]
24. Koehler BE, Richter KM, Youngblood L, et al. Reduction of 30-day postdischarge hospital
readmission or emergency department (ED) visit rates in high-risk elderly medical patients
through delivery of a targeted care bundle. J Hosp Med. 2009; 4:211–218. [PubMed: 19388074]
25. Institute for Safe Medication Practices. [Accessed March 10, 2010] ISMP’s List of High-Alert
Medications. http://www.ismp.org
26. North Carolina Board of Pharmacy. [Accessed March 23, 2010] North Carolina Narrow
Therapeutic Index list. http://ncbop.org/faqs/Pharmacist/faq_NTIDrugs.htm
27. Wong JD, Bajcar JM, Wong GG, et al. Medication reconciliation at hospital discharge: Evaluating
discrepancies. Ann Pharmacother. 2008; 42:1373–1379. [PubMed: 18780806]
28. Coleman EA, Parry C, Chalmers S, Min SJ. The care transitions intervention: Results of a
randomized controlled trial. Arch Intern Med. 2006; 166:1822–1828. [PubMed: 17000937]
29. Karapinar-Carkit F, Borgsteede SD, Zoer J, et al. Effect of medication reconciliation with and
without patient counseling on the number of pharmaceutical interventions among patients
discharged from the hospital. Ann Pharmacother. 2009; 43:1001–1010. [PubMed: 19491320]
30. Medicare Payment Advisory Commission. [Accessed March 23, 2010] A path to bundled payment
around a hospitalization. http://www.medpac.gov/chapters/Jun08_Ch04.pdf
31. Boockvar KS, Liu S, Goldstein N, et al. Prescribing discrepancies likely to cause adverse drug
events after patient transfer. Qual Saf Health Care. 2009; 18:32–36. [PubMed: 19204129]
Unroe et al. Page 10

























Unroe et al. Page 11
Table I
List of potentially high-risk medications from the Institute for Safe Medication Practices (ISMP) and the
North Carolina Narrow Therapeutic Index (NTI).25,26
ISMP
Classes/categories of medications
 Adrenergic agonists, IV (eg, epinephrine)
 Adrenergic antagonists, IV (eg, propranolol)
 Anesthetic agents, general, inhaled and IV (eg, propofol)
 Cardioplegic solutions
 Chemotherapeutic agents, parenteral and oral
 Dextrose, hypertonic, ≥20%
 Dialysis solutions, peritoneal and hemodialysis
 Epidural or intrathecal medications
 Glycoprotein IIb/IIIa inhibitors (eg, eptifibatide)
 Hypoglycemics, oral
 Inotropic medications, IV (eg, digoxin, milrinone)
 Liposomal forms of drugs (eg, liposomal amphotericin B)
 Moderate sedation agents, IV (eg, midazolam)
 Moderate sedation agents, oral, for children (eg, chloral hydrate)
 Narcotics/opiates, IV and oral (including liquid concentrates, immediate- and sustained-release formulations)
 Neuromuscular blocking agents (eg, succinylcholine)
 Radiocontrast agents, IV
 Thrombolytics/fibrinolytics, IV (eg, tenecteplase)




 Heparin, low molecular weight, injection
 Heparin, unfractionated, IV
 Insulin, subcutaneous and IV
 Lidocaine, IV
 Magnesium sulfate injection
 Methotrexate, oral, nononcologic use
 Nesiritide
 Nitroprusside sodium for injection
 Potassium chloride for injection concentrate
 Potassium phosphates injection
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Table III
Admission medication discrepancies grouped according to medication class and type of discrepancy. Data are
number (%)
Medication Class Medication Omitted Wrong Dose or Frequency Not Specified Any Discrepancy
Cardiovascular 10 (40) 0 15 (60) 25 (31)
Hormone-modifying 4 (40) 1 (10) 5 (50) 10 (12)
Hematologic/oncologic* 3 (30) 0 7 (70) 10 (12)
CNS 6 (60) 1 (10) 3 (30) 10 (12)
Gastrointestinal 3 (75) 0 1 (25) 4 (5)
Other† 4 (18) 1 (5) 17 (77) 22 (27)
Total 30 (37) 3 (4) 48 (59) 81 (100)
CNS = central nervous system.
*
Includes chemotherapeutic agents or adjuvant therapies.
†
Includes antimicrobial, musculoskeletal, dermatologic, autonomic, respiratory tract, and immune-modifying agents; antihistamines; vitamins/
minerals; topical eye, ear, nose, and throat agents; and those not stated or known.
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Table IV
Patient and hospitalization characteristics associated with medication discrepancies on admission: Logistic
regression analysis
Characteristic Univariate Odds Ratio (95% CI) P Multivariate Odds Ratio (95% CI) P
Age, continuous (per 5-year increase) 1.10 (0.99–1.23) 0.09 1.16 (1.01–1.33) 0.035
 <65y* – –
 ≥65 y 1.82 (0.90–3.70) 0.096
Sex
 Male 1.03 (0.51–2.07) 0.94
 Female* – –
Race
 White 1.21 (0.56–2.61) 0.63
 Black or other* – –
No. of comorbid conditions 1.03 (0.90–1.18) 0.65
Admitting service 0.036†
 Cardiology* – –
 General medicine 1.62 (0.64–4.06) 0.31
 General surgery 3.21 (1.29–7.98) 0.012 3.31 (1.40–7.87) <0.007
No. of medications on admission 1.03 (0.96–1.11) 0.42




P value for the overall test of significance for variables with several categories.
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Table VII
Patient and hospitalization characteristics associated with medication differences at discharge: Logistic
regression analysis
Characteristic Univariate Odds Ratio (95% CI) P
Age, continuous (per 5-year increase) 1.02 (0.82–1.28) 0.83
Age,y
 <65* – –
 ≥65 0.83 (0.18–3.80) 0.81
Sex
 Male 1.00 (0.22–4.59) 0.99
 Female* – –
Race
 White 0.76 (0.14–4.00) 0.74
 Black or other* – –
No. of comorbid conditions 0.90 (0.68–1.19) 0.45
Admitting service 0.65†
 Cardiology* – –
 General medicine 1.00 (0.20–5.13) 0.99
 General surgery 2.78 (0.28–27.4) 0.38
Length of stay 1.70 (0.97–3.00) 0.065
No. of medications on admission 1.01 (0.85–1.20) 0.89
No. of medications at discharge 1.12 (0.90–1.38) 0.31




P value for overall test of significance for variables with several categories.
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